Characterization of Trucut biopsy results in patients with BI-RADS 4 and 5 without surgical criteria
Keywords:
breast cancer, percutaneous biopsy, Tru-cutAbstract
Introduction: Percutaneous biopsy has become, nowadays, the most used diagnostic method to evaluate breast lesions suspected of malignancy.
Objective: To characterize the Tru-cut biopsy results in patients with BI-RADS 4 and 5 categories without surgical criteria.
Materials and methods: An observational, descriptive and cross-sectional study was carried out between January 2019 and December 2020 on 70 patients who presented who presented a lesion suspicious of malignancy by ultrasonography and required a thick-needle biopsy of the reported image. They were performed at the Breast Intervention Clinic of the Imaging Department of the Clinical Surgical University Hospital Comandante Faustino Pérez Hernández, from Matanzas. The variables age, BI-RADS category, histopathological result, tumor size and complications were analyzed.
Results: The predominant age group was the 70-79 years-old one (27.1). 48 patients were classified with BI-RADS 5 category, for 68.6%. Infiltrating ductal carcinoma resulted the predominant histological type, with 40 patients representing 57.1% of the total. An average diameter of 28.91 mm was obtained from the biopsied lesions. All samples were useful, even in transverse diameters less than 2cm. In the series, few complications were reported.
Conclusion: Biopsy performed with thick needle under ultrasound guidance with free-hands technique, is a reliable method for breast cancer diagnosis, safe and without serious complications. It is confirmed that BI-RADS 5 category coincides with breast cancer pathological diagnosis.
Downloads
References
2. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2020 [Internet]. La Habana: Ministerio de Salud Pública de Cuba; 2021 [citado 11/06/2021]. Disponible en: https://salud.msp.gob.cu/wp-content/Anuario/Anuario-2020.pdf
3. Miguel Soca P, Argüelles González I, Peña González M. Factores genéticos en la carcinogénesis mamaria. Rev Finlay [Internet]. 2016 [citado 22/09/2019];6(4):299-316. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2221-24342016000400007&lng=es
4. Ponce Partida RK, Murillo Ortiz BO, Rivera Villanueva TM, et al. Concordancia entre reporte BIRADS por radiología intervencionista y diagnóstico histopatológico en pacientes con biopsia de mama. Rev Mex Mastol [Internet]. 2019 [citado 13/12/2021];9(2-3):44-52. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=95807
5. Osorio Bazar N, Bello Hernández C, Vega Bazar L. Factores de riesgo asociados al cáncer de mama. Rev Cubana Med Gen Integr [Internet]. 2020 [citado 02/04/2022];36(2):e1147. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S0864-21252020000200009
6. Gámez Oliva H, Blanco González Y, Ramos Ferro M, et al. Impacto de la realización de la biopsia por trucut en el diagnóstico de tumores mamarios. Rev Cubana Invest Bioméd [Internet]. 2015 [citado 11/01/2022];34(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002015000100010
7. Sun T, Zhang H, Gao W, et al. The appropriate number of preoperative core needle biopsy specimens for analysis in breast cancer. Medicine (Baltimore) [Internet]. 2021 [citado 11/01/2022];100(14):e25400. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036035/
8. Jung I, Han K, Kim MJ, et al. Annual Trends in Ultrasonography-Guided 14-Gauge Core Needle Biopsy for Breast Lesions. Korean J Radiol. 2020;21(3):259-67. DOI: 10.3348/kjr.2019.0695.
9. Versaggi SL, De Leucio A. Breast Biopsy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [citado 15/03/2023]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK559147/
10. Dhamija E, Singh R, Mishra S, et al. Image-Guided Breast Interventions: Biopsy and Beyond. Indian J Radiol Imaging. 2021;31(2):391-9. DOI: 10.1055/s-0041-1734223.
11. Okoli C, Ebubedike U, Anyanwu S, et al. Biopsia central de lesiones mamarias guiada por ultrasonido en un entorno de recursos limitados: experiencia inicial de un equipo multidisciplinario. Eur J Breast Health. 2020;16(3):171-6. DOI: 10.5152/ejbh.2020.5075.
12. Camacho-Piedra C, Espíndola-Zarazúa V. Actualización de la nomenclatura BI-RADS® por mastografía y ultrasonido. An Radiol Méx [Internet]. 2018 [citado 11/01/2022];17:100-8. Disponible en: https://www.medigraphic.com/pdfs/anaradmex/arm-2018/arm182d.pdf
13. Ferretti S, Renati E, Ferreyra B, et al. Experiencia de Biopsia Core Mamaria Ecoguiada. Relación entre BI-RADS y resultado anatomopatologico. Rev Arg Mastol [Internet]. 2016 [citado 11/01/2022];35(126):18-26. Disponible en: https://www.revistasamas.org.ar/revistas/2016_v35_n126/3.pdf
14. Kresovich JK, Xu Z, O'Brien KM, et al. Methylation-Based Biological Age and Breast Cancer Risk. J Natl Cancer Inst. 2019;111(10):1051-8. DOI: 10.1093/jnci/djz020.
15. Ceballos Morales A, Burgos Portales D, Carrasco Portiño M, et al. Caracterización del cáncer de mama de un servicio de salud pública del sur de Chile según edad, período 2005-2015. Rev Chil Obstet Ginecol [Internet]. 2021 [citado 02/04/2022];86(2):175-85. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262021000200175&lng=es
16. De la Cruz Castillo NA, Lambert HO, Ramírez JMR, et al. Análisis de la mortalidad por cáncer de mama, tendencias y pronóstico en Santiago de Cuba. Rev Cubana Cir [Internet]. 2019 [citado 02/04/2022];58(4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-74932019000400004
17. Gómez Lloga T, Franco de la Iglesia Y, Noa Garbey M, et al. Incidencia de cáncer de mama en mujeres de la provincia de Guantánamo en el periodo 2015-2016. Rev Inf Cient [Internet]. 2017 [citado 02/04/2022];96(5):866-74. Disponible en: https://www.medigraphic.com/pdfs/revinfcie/ric-2017/ric175h.pdf
18. Luthy IA. Tamizaje del cáncer de mama: Certezas y controversias. Medicina (B. Aires) [Internet]. 2017 [citado 02/04/2022];77(5):437-9. Disponible en: https://ri.conicet.gov.ar/handle/11336/36416
19. Gil-Enríquez DM, García-Calderón MR. Cáncer de mama en pacientes de 70 años y más, hallazgos radiológicos y su correlación histopatológica. An Radiol Méx [Internet]. 2019 [citado 02/04/2022];18:84-98. Disponible en: https://www.medigraphic.com/pdfs/anaradmex/arm-2019/arm192d.pdf
20. Villegas-Carlos F, Andino-Araque V, Valverde-Quintana M, et al. Predictive factors of invasion in ductal carcinoma in situ diagnosed by core-needle biopsy. Cir Cir [Internet]. 2022 [citado 15/03/2023];90(1):41-9. DOI: 10.24875/CIRU.21000136.
21. Liu Y, Wang X, Zheng A, et al. Breast Lesions Diagnosed as Ductal Carcinoma In Situ by Ultrasound-Guided Core Needle Biopsy: Risk Predictors for Concomitant Invasive Carcinoma and Axillary Lymph Node Metastasis. Front Oncol. 2021;11:717198. DOI: 10.3389/fonc.2021.717198.
22. Ortiz Giménez R, Fernández Gómez JA, Sainz Martínez JM, et al. Correlación de la semiología ecográfica de las lesiones birads 4 y 5 de la mama con su resultado anatomopatológico. Seram [Internet]. 2018 [citado 02/04/2022]. Disponible en: https://piper.espacio-seram.com/index.php/seram/article/view/3088
23. Noonpradej S, Wangkulangkul P, Woodtichartpreecha P, et al. Prediction for Breast Cancer in BI-RADS Category 4 Lesion Categorized by Age and Breast Composition of Women in Songklanagarind Hospital. Asian Pac J Cancer Prev. 2021;22(2):531-6. DOI: 10.31557/APJCP.2021.22.2.531.
24. Magny SJ, Shikhman R, Keppke AL. Breast Imaging Reporting and Data System. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [citado 15/03/2023]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK459169/
25. Bick U, Trimboli RM, Athanasiou A, et al. Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging. Insights Imaging. 2020;11(1):12. DOI: 10.1186/s13244-019-0803-x.
Downloads
Published
How to Cite
Issue
Section
License
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.
Guidelines to authors
